Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 07, 2020

SELL
$1.59 - $2.51 $5,247 - $8,283
-3,300 Closed
0 $0
Q1 2020

May 04, 2020

SELL
$1.39 - $3.19 $104 - $239
-75 Reduced 2.22%
3,300 $6,000
Q4 2019

Feb 04, 2020

SELL
$1.96 - $2.81 $2,114 - $3,031
-1,079 Reduced 24.23%
3,375 $9,000
Q3 2019

Nov 12, 2019

BUY
$2.12 - $9.37 $9,442 - $41,733
4,454 New
4,454 $10,000

Others Institutions Holding SYBX

About SYNLOGIC, INC.


  • Ticker SYBX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,229,600
  • Market Cap $96.9M
  • Description
  • Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...
More about SYBX
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.